Treatment-resistant hypertension
Poor control over cholesterol levels
Personal history of angina, DVT, PE, CHF, MI or CVA
Introduction of new statin medications
Family history of cardiovascular disease
Stroke or heart disease in the young
Idiopathic cardiovascular disease
The Kashi Cardiac Health Panel gives insight into how a patient’s genetic predisposition to cardiac problems can help healthcare providers optimize diagnosis and treatment.
Cardiovascular disease is a leading contributor to morbidity and mortality, with over 17 million deaths occurring annually worldwide. Risk increases in adults over the age of 60, and in part is attributable to inherited genetic makeup.
Cardiovascular disease – which includes coronary heart disease, cerebrovascular disease, peripheral artery disease, and atherosclerosis – is heavily influenced by factors such as insulin resistance, hypertension, dyslipidemia, inflammation, and coagulation properties. Many of these factors can be mitigated by lifestyle changes including smoking cessation, increasing aerobic exercise, and eating a well-balanced diet, which can reduce the risk of catastrophic events such as myocardial infarction, or ischemic and hemorrhagic stroke. However, in some cases, particularly where family history of cardiovascular disease is prevalent, medications or more targeted lifestyle interventions are needed to better manage health outcomes.
ApoE 4 does not guarantee that someone will develop Alzheimer’s. After learning about an individual’s genetic makeup, we can recommend steps to take to reduce your risk of developing the disease.
ApoE
Impacts management of cholesterol levels and risk of heart attack, stroke, hypertension, and coronary disease
Factor II (Prothrombin)
Affects the body’s ability to form blood clots which is tied to the risk of many cardiovascular-related health outcomes
Factor V
Enhances body’s coagulability which leads to thromboembolisms
MTHFR
Contributes to increased levels of homocysteine, a known risk factor for heart disease, atherosclerosis, and peripheral neuropathy
9p21
Associated with cellular growth and proliferation in relation to atherosclerosis, arterial stiffness and coronary artery disease
eNOS/NOS3
Influences nitric oxide levels leading to risk of endothelial dysfunction, and many subsequent cardiovascular effects
SLCO1B1*5
Modulates the body’s ability to metabolize statin medications, which are commonly prescribed to improve cholesterol
AGT
Key to maintaining blood pressure, patients who carry this mutation may be at an increased risk of developing hypertension
T — (877) 879-1815
F — (503) 206-6939
10101 SW Barbur Blvd
Suite 200
Portland, OR 97219
Monday-Friday
8:00am-6:30pm
Excluding the following holidays: New Year's Day, Memorial Day, Independence Day, Labor Day, Thanksgiving Day and Christmas Day.
© Copyright 2024 Kashi Clinical Laboratories
To request environmental testing at Kashi Labs, please visit the Order Now page and contact us to get started.
To request toxicology testing at Kashi Labs, please visit the Order Now page and contact us to get started.
If you are an existing provider, please sign in to place an order through the online portal. If you are new to Kashi and would like to create an account, please contact us.
Place a one-time order by contacting us through the form at the link below, or get started by logging in to your online portal.
BoneMarrowTest.com is a service of Kashi Clinical Laboratories. For more information regarding Private HLA Testing or to order a test kit, please visit BoneMarrowTest.com.
*By clicking the link above you will be redirected to BoneMarrowTest.com.
To place an order or find more information regarding MMDx® for Molecular Biopsy Assessment, sample reports, and free specimen collection kit orders, please click the order button.
*By clicking the link above you'll be redirected to the ThermoFisher Scientific website.